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We aimed to identify the region harboring a putative candidate gene associated with hip-
pocampal abnormalities (HAb) in a family with mesial temporal lobe epilepsy (MTLE).
Genome-wide scan was performed in one large kindred with MTLE using a total of 332
microsatellite markers at∼12 cM intervals. An additional 13 markers were genotyped in the
candidate region. Phenotypic classes were defined according to the presence of hippocam-
pal atrophy and/or hyperintense hippocampal T2 signal detected on magnetic resonance
imaging. We identified a significant positive LOD score on chromosome 18p11.31 with a
Z max of 3.12 at D18S452. Multipoint LOD scores and haplotype analyses localized the
candidate locus within a 6-cM interval flanked by D18S976 and D18S967. We present here
evidence that HAb, which were previously related mainly to environmental risk factors,
may be influenced by genetic predisposition. This finding may have major impact in the
study of the mechanisms underlying abnormalities in mesial temporal lobe structures and
their relationship with MTLE.
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INTRODUCTION
The association between mesial temporal lobe epilepsy (MTLE)
and hippocampal sclerosis (HS) has been well established; as well
as the use of hippocampal atrophy (HA) and abnormal hippocam-
pal signal, observed on magnetic resonance imaging (MRI), as an
in vivo surrogate marker of HS (Berkovic et al., 1991; Cendes et al.,
1993; Van Paesschen et al., 1997). Although the precise pathogen-
esis of mesial temporal sclerosis (MTS) and its relationship with
MTLE is not completely clarified, it has been frequently associated
with environmental predisposing factors,mainly an increased inci-
dence of prolonged childhood febrile seizures (Abou-Khalil et al.,
1993; VanLandingham et al., 1998).
We have described previously clinical and imaging features
of a type of MTLE associated with HA, showing familial recur-
rence and low frequency of febrile seizures (Kobayashi et al., 2001,
2002, 2003). Most affected individuals in familial MTLE have a
mild phenotype with a benign form of MTLE (Kobayashi et al.,
2001). HA with or without hyperintense T2 signal on MRI was
observed in most patients, including those with a single focal
seizure, seizure remission (Kobayashi et al., 2003) as well as in
34% of asymptomatic first-degree relatives of patients with famil-
ial MTLE (Kobayashi et al., 2002). These reports suggest that
hippocampal abnormalities (HAb) identified by MRI in famil-
ial MTLE have a genetic predisposition and it is not necessarily
associated to seizures in all patients (Kobayashi et al., 2001; Coan
et al., 2004).
In the present study we report the results of a genome-wide
linkage study, which identifies the candidate region harboring a
putative gene associated with MRI signs of HAb in a family with
MTLE.
MATERIALS AND METHODS
FAMILY
Familial MTLE was identified when two or more individuals pre-
sented the diagnosis of MTLE, which was based on clinical and
electroencephalographic (EEG) findings as defined by the Inter-
national League against Epilepsy (ILAE) criteria (ILAE, 1989). For
this study we selected one single informative kindred for link-
age analysis, named F-10, in order to avoid the risk of genetic
heterogeneity.
MAGNETIC RESONANCE IMAGING
Magnetic resonance imagings were performed in a 2-T scan-
ner including thin (1–3 mm) coronal T1-weighted images and
T2-weighted coronal images, perpendicular to long axis of the
hippocampal formation as described in Cendes et al. (1998) and
Kobayashi et al. (2001, 2002).
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Manual volumetry was performed using software developed by
the National Institutes of Health (NIH-Image, National Institutes
of Health, Bethesda, MD, USA) and anatomic guidelines were
based on a standard protocol. Hippocampal volumes and asym-
metry index (AI) for each patient (defined as the ratio of the
smaller by the larger hippocampus) were compared to 30 healthy
controls. Values that were 2 SDs below the mean values of control
group were considered abnormal. Visual analysis was also per-
formed looking for increased T2 signal and abnormal shape and
axis of the hippocampus. Presence of HAb was identified if any
abnormality was present.
Prior to genetic analysis, family members were classified into
three phenotypic classes according to MRI findings: (1) affected :
individuals with HAb detected by MRI, defined as: (i) HA,
(ii) hyperintense T2 signal, (iii) abnormal shape or axis of the
hippocampus, or (iv) any combination of these three findings
(Kobayashi et al., 2002); (2) unaffected : individuals with no HAb
detected by MRI; (3) unknown: individuals with no MRI infor-
mation. Previous to enrollment, all family members provided
informed consent which was approved by the Research Ethics
Committee of our Institution.
GENOTYPING
DNA was isolated from peripheral lymphocytes of fresh blood
by standard methods (Sambrook et al., 1989) and genotyped
for an in-house customized panel of 332 microsatellite markers
regularly spaced at ∼12 cM intervals throughout the 22 auto-
somal chromosomes. Microsatellite markers were chosen from
the sex-average map of the Marshfield Human Genetic Map1
with a polymorphism information content (PIC) >75%. The
correct orientation of markers was obtained using the NCBI
Map Viewer2. Genotyping was carried out using capillary elec-
trophoresis on MegaBACE™ 1000 96-capillary sequencers (GE
Healthcare, Buckinghamshire, UK). The fluorescent dye-labeled
primers (FAM™, VIC™, NED™) were customized or chosen from
the MD10 panel set (Applied Biosystems, Foster City, CA, USA).
Samples amplified by PCR and labeled with different dyes were
pooled in a final volume of 40µl H2O (1:20 for FAM™, 1:20
for VIC™, and 1:10 for NED™) in a 96-wells plate. Two micro-
liters were transferred to a MegaBACE 96-wells plate and mixed
with 8µl of a loading solution (for each reaction: 7.75µl of
0.1% Tween 20 in H2O+ 0.25µl of internal size standard labeled
with ROX™ dye, ET-550R; GE Healthcare, Buckinghamshire,
UK). Automatic calling of genotypes was based on the Frag-
ment Profiler Software v1.2 (GE Healthcare, Buckinghamshire,
UK). In addition we used a software developed in-house for
processing output data from Fragment Profiler and to estimate
allelic frequency (Secolin et al., 2008). Mendelian inconsistencies
were evaluated by PEDCHECK program (O’Connell and Weeks,
1998).
FINE MAPPING
Thirteen additional markers were genotyped on chromo-
some 18p in order to refine the candidate region: telomere,
1http://www.research.marshfieldclinic.org/genetics
2http://www.ncbi.nlm.nih.gov/mapview
D18S476, D18S1098, D18S481, D18S1154, D18S52, D18S1132,
D18S976, D18S1376, D18S967, D18S1163, D18S464, D18S1150,
and D18S1158, centromere.
LINKAGE ANALYSIS
Linkage analysis was performed under the assumption of a dom-
inant mode of inheritance (Secolin et al., 2010) with 85% pen-
etrance which was calculated based on data obtained directly
from F-10 using a method proposed by Wang et al. (2006).
Gene frequency of the mutated allele was set at 0.00025. Two-
point LOD scores were calculated using the MLINK program,
version 5.2 (CEPH, University of Utah and Columbia Univer-
sity, 1990), from the LINKAGE computer package (Lathrop and
Lalouel, 1984; Terwilliger and Ott, 1994). In order to further
narrow down the candidate region on chromosome 18p we
carried out a multipoint linkage analysis using the LINKMAP
support program from the LINKAGE package (Lathrop et al.,
1985).
RESULTS
A total of 28 individuals, including 14 patients, were genotyped.
Clinical and MRI data of F-10 are shown in Table 2. The results
of the genome-wide linkage study are summarized in Figure 1.
Overall, we found only one single significant positive LOD score
on chromosome 18p (Figure 1). Fine mapping of the candidate
region identified a Zmax of 3.12 at θ= 0.0 at the D18S452 locus
(Table 1).
Haplotype analysis showed 12 affected individuals segregating
the haplotype predicted to carry the candidate gene in F-10, indi-
cating a critical region of 6 cM between markers at D18S976 and
D18S967 loci (see individual III-3 in Figure 2).
However, the “affected” haplotype was also present in two
individuals that are obligatory carries of the candidate gene muta-
tion (individuals III-11 and III-12), but who were phenotypically
classified as unknown and unaffected, respectively. In addition,
haplotype analysis also showed two individuals who were con-
sidered affected, but who did not carry the “affected” haplotype
(individuals II-12 and II-13). Multipoint analysis (Figure 3) con-
firms the mapping of the candidate region to a ∼6-cM interval
between loci D18S976 and D18S967.
DISCUSSION
We identified a candidate locus on chromosome 18p11.31 associ-
ated with HAb in a family with MTLE.
Over the past 20 years, the progress in molecular genetics has
lead to the identification of candidate loci and mutated genes
in many epilepsy syndromes (Ottman, 2001). In temporal lobe
epilepsy (TLE), a digenic inheritance with loci on 1q25–31 and
18qter and another locus on 12q22–q23.3 were described for famil-
ial TLE with febrile seizures (Baulac et al., 2001; Claes et al., 2004).
Subsequently, a locus for familial MTLE was identified on chro-
mosome 4q13.2–q21.3 by Hedera et al. (2007), but in contrast
with F-10, none of the patients reported had MRI signs of HAb.
Therefore, it becomes clear that locus heterogeneity is present
even within the so-called familial forms of MTLE confirming
the trend already seen in several other types of familial epilepsy
syndromes (Baulac et al., 2001; Claes et al., 2004; Hedera et al.,
2007).
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FIGURE 1 | Diagram representing the results of two-point LOD scores for
the 332 microsatellites markers genotyped in the genome-wide linkage
study of F-10 segregating familial mesial temporal lobe epilepsy.
Horizontal lines mark the upper and lower limits for LOD score significance.
The arrow indicates the single significant positive LOD score found in the
genome scan.
Table 1 |Two-point LOD scores for the markers genotyped in the candidate region for familial temporal lobe epilepsy in the family F-10.
Marker Recombination fraction (θ)
0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40
F-10
D18S476 2.36 2.33 2.20 2.00 1.77 1.50 1.20 0.88 0.54
D18S1098 1.17 1.23 1.20 1.11 0.99 0.84 0.66 0.47 0.26
D18S481 2.17 2.40 2.40 2.29 2.09 1.82 1.51 1.14 0.73
D18S1154 1.37 1.45 1.43 1.35 1.23 1.09 0.92 0.73 0.51
D18S52 2.21 2.40 2.37 2.24 2.04 1.77 1.46 1.10 0.70
D18S1132 1.82 2.07 2.10 2.00 1.83 1.58 1.29 0.95 0.58
D18S976 1.87 2.13 2.17 2.08 1.91 1.67 1.39 1.06 0.70
D18S1376 0.50 0.46 0.42 0.38 0.33 0.28 0.23 0.18 0.12
D18S452 3.12 3.10 2.95 2.72 2.43 2.09 1.70 1.28 0.83
D18S967 −0.00 −0.00 −0.00 −0.00 0.00 0.00 0.00 0.00 0.00
D18S1163 −0.83 −0.52 −0.34 −0.23 −0.15 −0.09 −0.06 −0.03 −0.01
D18S464 −0.03 0.01 0.04 0.05 0.06 0.07 0.06 0.06 0.04
D18S1150 −3.97 −2.58 −1.72 −1.13 −0.71 −0.39 −0.17 −0.03 0.04
D18S1158 −2.95 −1.56 −0.99 −0.63 −0.40 −0.24 −0.13 −0.07 −0.03
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FIGURE 2 | Haplotype analysis of F-10 for 14 markers localized
on chromosome 18p. The haplotype inherited by affected individuals
is represented by blackened vertical bars. Family members who did
not participate in the linkage study are not shown. Individual III-3
shows a critical recombination event. IP, Incomplete Penetrance; Ph,
Phenocopy.
FIGURE 3 | Multipoint linkage analysis on chromosome 18p depicting
the candidate region for the putative gene causing the phenotype in
F-10. Horizontal lines mark the upper and lower limits for LOD score
significance. The single horizontal dotted line indicates the upper limit of
the 95% confidence interval calculated for the maximum LOD score
achieved. Arrows between vertical lines identify the critical region (6 cM)
expected to contain the candidate gene flanked by markers at D18S967
and D18S976 loci.
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Table 2 | Clinical information for family F-10.
Individual Clinical group Volume IncreasedT2 Abnormal shape Seizure EEG Seizures “Affected”
signal or axis onset haplotype
I-2 asymp BHA Yes Yes – NA – Yes
II-1 MTLE remis normal No Yes 9 NA SP, SG Yes
II-3 single sz LHA No No 35 NA SP, CP Yes
II-5 G Normal No No 12 Normal G No
II-7 bg MTLE Normal No Yes Childhood NA CP, SG Yes
II-8* G BHA Yes Yes Childhood NA G Yes
II-11 MTLE remis RHA No Yes 19 NA SP, CP, SG Yes
II-12** MTLE remis Normal Yes Yes 8 NA SP, G No
II-13 MTLE remis LHA Yes Yes 8 NA SP, CP No
II-15 bg MTLE Normal No Yes 6 NA SP, CP, SG Yes
II-16 asymp Normal No No – NA – No
III-1 asymp NA NA NA – NA – No
III-2 bg MTLE LHA Yes Yes 2 NA SP, CP, SG Yes
III-3 bg MTLE BHA No Yes 5 Normal SP, CP, SG Yes
III-4 bg MTLE BHA Yes Yes 14 LT ED SP, CP, SG Yes
III-5* G Normal No No 14 RT SW G No
III-6 asymp Normal No No – NA – No
III-7 bg MTLE Normal No Yes 6 RT SW CP, SG Yes
III-8 asymp NA NA NA – NA – No
III-9 asymp NA NA NA – NA – No
III-10 G BHA Yes Yes 5 NA G Yes
III-11 single sz NA NA NA 19 NA SP, SG Yes
III-12 asymp No No No – NA – Yes
III-13*** asymp Normal No No – NA – No
III-14 asymp Normal No No – NA – No
III-15 SP Normal No No 8 Normal SP No
LHA, left hippocampal atrophy; RHA, right hippocampal atrophy; BHA, bilateral hippocampal atrophy; SP, simple partial seizure; bg MTLE, benign mesial temporal lobe
epilepsy; MTLE remis, mesial temporal lobe epilepsy with remission; G, generalized; asymp, asymptomatic; single sz, single seizure; RT SW, right temporal slow
waves; LT ED, left temporal epileptiform discharges; CP, complex partial seizures; SG, secondary generalized seizures; G, generalized. NA, not available. *Nocturnal
unwitnessed generalized seizures, impossible to define if the onset was partial; **G seizures from 8 to 12 years; ***left frontal glial tumor.
Here we report a family which is part of a larger cohort showing
a distinct type of familial MTLE associated with MRI signs of HAb,
which also presents a low frequency of febrile seizures (Kobayashi
et al., 2001). In the present study we used MRI signs of HAb to
classify individuals as affected, independently of the presence of
seizures (individual I-2, F-10; Kobayashi et al., 2002, 2003; Coan
et al., 2004).
Although we had a reliable biological maker for phenotypic
characterization, there were still difficulties with the MRI char-
acterization of all individuals enrolled in the study. We could
not ascertained the MRI-phenotypic status of individual III-11,
since he presented claustrophobia and was unable to complete
the exam; therefore, individual III-11 was considered unknown
despite the fact that he carries the affected haplotype; thus, at
this point we cannot completely exclude the possibility that he
may have an abnormal MRI. Individual III-12 carries the affected
haplotype but he had no MRI abnormalities, even when he was
subsequently examined in a 3T MRI scan (data not shown); there-
fore, he may represent an example of incomplete penetrance. In
fact, we estimated the penetrance in our linkage analysis at 85%.
Incomplete penetrance is not unusual in familial epilepsies (John-
son et al., 1996; Striano et al., 2008) and it accounts for part of the
complex relationship observed between genotype and phenotype
in different epilepsy syndromes (Anderson et al., 2002; Ottman,
2005).
In addition, we identified two individuals (II-12 and II-13),
who were considered affected, since they had MRI abnormalities
(Table 2) but did not present the “affected” haplotype (Figure 2).
Individual II-12 had an increased T2 signal and abnormal shape
of the hippocampus and individual II-13 had left HA. Individual
II-12 has a history of heavy alcohol intake, a well-known cyto-
toxic agent which can cause hippocampal damage (Sullivan et al.,
1995; Agartz et al., 1999); thus, we raise the possibility that one or
both individuals could be phenocopies. Therefore, at this point,
we cannot completely exclude the possibility that the abnormali-
ties seen on MRI of both individuals may be due to factors other
than the mutated gene on chromosome 18p11.31 segregating in
this family.
The combined results of multipoint LOD scores and haplotype
data points to a candidate interval of 6 cM between D18S976 and
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FIGURE 4 | Schematic representation of chromosome 18 indicating the region likely to contain the candidate locus identified in F-10.
D18S 967. A search in the NCBI3 and Ensembl database4 showed
at least three genes (Figure 4), which could play a role in the
pathogenesis of HS such as: ZFP161 (zinc finger protein,161, MIM
602126) a gene involved in CNS development and recently pointed
out as a candidate for holoprosencephaly (Sobek-Klocke et al.,
1997; Lee et al., 2004); L3MBTL4 [L(3)mbt-like 4 (Drosophila),
gene ID91133], which functions as a cell adhesion molecule
and EPB41L3 (erythrocyte membrane protein band 4.1-like3, MIM
605331) that encodes a family of proteins likely to take part in
skeletal structures of cells and it is highly expressed in the brain
(Peters et al., 1998). In addition, we identified the TTMA gene
(two transmembrane domain family member A, gene ID 645369),
and five hypothetical proteins localized in this candidate region.
Mutation screening in candidate genes located within the 18p11.31
3http://www.ncbi.nlm.nih.gov
4http://www.ensembl.org
region is under way in order to identify the gene responsible for
this disease.
In conclusion, we identified a candidate locus for HAb asso-
ciated with familial MTLE on chromosome 18p11.31 suggesting
that a major gene predisposing to HS is present in patients from
family F-10. This is strong evidence suggesting that genetic causes
leading to hippocampal damage can also be related to MTLE.
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